CAR-T cells forge ahead, Novartis reorganizes

Nat Biotechnol. 2016 Nov 8;34(11):1079-1081. doi: 10.1038/nbt1116-1079.
No abstract available

MeSH terms

  • Drug Discovery*
  • Drug Industry / trends*
  • Humans
  • Receptors, Antigen / genetics*
  • Receptors, Antigen / metabolism*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism*
  • T-Lymphocytes / physiology*

Substances

  • Receptors, Antigen
  • Recombinant Proteins